NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 247 filers reported holding NEKTAR THERAPEUTICS in Q1 2022. The put-call ratio across all filers is 1.00 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $4,000 | -20.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $5,000 | 0.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $5,000 | -16.7% | 300 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $6,000 | +20.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $5,000 | -75.0% | 300 | -75.0% | 0.00% | -83.3% |
| Q3 2020 | $20,000 | -28.6% | 1,200 | 0.0% | 0.01% | -33.3% |
| Q2 2020 | $28,000 | +33.3% | 1,200 | 0.0% | 0.01% | +12.5% |
| Q1 2020 | $21,000 | -19.2% | 1,200 | 0.0% | 0.01% | 0.0% |
| Q4 2019 | $26,000 | +18.2% | 1,200 | 0.0% | 0.01% | 0.0% |
| Q3 2019 | $22,000 | -48.8% | 1,200 | 0.0% | 0.01% | -46.7% |
| Q2 2019 | $43,000 | +7.5% | 1,200 | 0.0% | 0.02% | 0.0% |
| Q1 2019 | $40,000 | +2.6% | 1,200 | 0.0% | 0.02% | -6.2% |
| Q4 2018 | $39,000 | – | 1,200 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 432,952 | $1,385,000 | 0.91% |
| GREAT POINT PARTNERS LLC | 447,820 | $1,433,000 | 0.34% |
| Birchview Capital, LP | 128,000 | $410,000 | 0.29% |
| Edgestream Partners, L.P. | 1,047,636 | $3,352,000 | 0.26% |
| Rhenman & Partners Asset Management AB | 550,000 | $2,068,000 | 0.22% |
| CM Management, LLC | 50,000 | $160,000 | 0.18% |
| TANG CAPITAL MANAGEMENT LLC | 430,037 | $1,376,000 | 0.17% |
| PDT Partners, LLC | 307,953 | $985,000 | 0.15% |
| Virtus ETF Advisers LLC | 72,018 | $230,000 | 0.09% |
| ALGERT GLOBAL LLC | 476,412 | $1,525,000 | 0.09% |